nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—ORM1—Vismodegib—skin cancer	0.181	0.21	CbGbCtD
Propranolol—ORM1—Vemurafenib—skin cancer	0.143	0.166	CbGbCtD
Propranolol—CYP1A2—Imiquimod—skin cancer	0.0657	0.0763	CbGbCtD
Propranolol—CYP1A1—Dacarbazine—skin cancer	0.0617	0.0717	CbGbCtD
Propranolol—CYP2C19—Vismodegib—skin cancer	0.0493	0.0573	CbGbCtD
Propranolol—ABCB1—Vismodegib—skin cancer	0.0398	0.0463	CbGbCtD
Propranolol—CYP1A2—Vemurafenib—skin cancer	0.036	0.0418	CbGbCtD
Propranolol—CYP3A4—Temozolomide—skin cancer	0.0344	0.04	CbGbCtD
Propranolol—CYP3A4—Imiquimod—skin cancer	0.0344	0.04	CbGbCtD
Propranolol—CYP2D6—Vemurafenib—skin cancer	0.0296	0.0345	CbGbCtD
Propranolol—CYP1A2—Dacarbazine—skin cancer	0.0276	0.032	CbGbCtD
Propranolol—CYP3A4—Vismodegib—skin cancer	0.0238	0.0277	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0221	0.0257	CbGbCtD
Propranolol—CYP3A7—Docetaxel—skin cancer	0.0221	0.0257	CbGbCtD
Propranolol—ABCB1—Dactinomycin—skin cancer	0.0209	0.0243	CbGbCtD
Propranolol—CYP3A4—Vemurafenib—skin cancer	0.0188	0.0219	CbGbCtD
Propranolol—CYP3A5—Docetaxel—skin cancer	0.0166	0.0193	CbGbCtD
Propranolol—CYP1A2—Fluorouracil—skin cancer	0.0162	0.0188	CbGbCtD
Propranolol—ABCB1—Docetaxel—skin cancer	0.0108	0.0125	CbGbCtD
Propranolol—CYP3A4—Docetaxel—skin cancer	0.00647	0.00752	CbGbCtD
Propranolol—Fatigue—Vismodegib—skin cancer	0.00094	0.00673	CcSEcCtD
Propranolol—Pain—Vismodegib—skin cancer	0.000932	0.00667	CcSEcCtD
Propranolol—Constipation—Vismodegib—skin cancer	0.000932	0.00667	CcSEcCtD
Propranolol—Erectile dysfunction—Imiquimod—skin cancer	0.00093	0.00666	CcSEcCtD
Propranolol—Disorientation—Bleomycin—skin cancer	0.000928	0.00664	CcSEcCtD
Propranolol—Infestation NOS—Imiquimod—skin cancer	0.000901	0.00645	CcSEcCtD
Propranolol—Infestation—Imiquimod—skin cancer	0.000901	0.00645	CcSEcCtD
Propranolol—Depression—Imiquimod—skin cancer	0.000898	0.00643	CcSEcCtD
Propranolol—Erythema multiforme—Vemurafenib—skin cancer	0.000896	0.00642	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.000893	0.00639	CcSEcCtD
Propranolol—Gastrointestinal pain—Vismodegib—skin cancer	0.000892	0.00638	CcSEcCtD
Propranolol—Dry eye—Temozolomide—skin cancer	0.000891	0.00638	CcSEcCtD
Propranolol—Throat sore—Docetaxel—skin cancer	0.00089	0.00637	CcSEcCtD
Propranolol—Oropharyngeal discomfort—Docetaxel—skin cancer	0.000882	0.00631	CcSEcCtD
Propranolol—Cardiac disorder—Vemurafenib—skin cancer	0.00088	0.0063	CcSEcCtD
Propranolol—Abdominal pain—Vismodegib—skin cancer	0.000862	0.00617	CcSEcCtD
Propranolol—Rash erythematous—Docetaxel—skin cancer	0.000838	0.006	CcSEcCtD
Propranolol—Alopecia—Vemurafenib—skin cancer	0.000838	0.006	CcSEcCtD
Propranolol—Erythema—Vemurafenib—skin cancer	0.000825	0.00591	CcSEcCtD
Propranolol—Pharyngitis—Imiquimod—skin cancer	0.000802	0.00574	CcSEcCtD
Propranolol—Lethargy—Dactinomycin—skin cancer	0.00079	0.00566	CcSEcCtD
Propranolol—Vascular purpura—Temozolomide—skin cancer	0.000783	0.0056	CcSEcCtD
Propranolol—Asthenia—Vismodegib—skin cancer	0.000782	0.0056	CcSEcCtD
Propranolol—Visual impairment—Imiquimod—skin cancer	0.000779	0.00558	CcSEcCtD
Propranolol—Erythema multiforme—Imiquimod—skin cancer	0.000764	0.00547	CcSEcCtD
Propranolol—Diarrhoea—Vismodegib—skin cancer	0.000746	0.00534	CcSEcCtD
Propranolol—Amnesia—Temozolomide—skin cancer	0.000745	0.00534	CcSEcCtD
Propranolol—Dermatitis exfoliative—Temozolomide—skin cancer	0.000742	0.00531	CcSEcCtD
Propranolol—Purpura—Temozolomide—skin cancer	0.000727	0.0052	CcSEcCtD
Propranolol—Disorientation—Fluorouracil—skin cancer	0.000721	0.00516	CcSEcCtD
Propranolol—Cough—Vemurafenib—skin cancer	0.00072	0.00515	CcSEcCtD
Propranolol—Alopecia—Imiquimod—skin cancer	0.000714	0.00511	CcSEcCtD
Propranolol—Mental disorder—Imiquimod—skin cancer	0.000708	0.00507	CcSEcCtD
Propranolol—Bronchospasm—Bleomycin—skin cancer	0.000706	0.00505	CcSEcCtD
Propranolol—Oropharyngeal pain—Docetaxel—skin cancer	0.000706	0.00505	CcSEcCtD
Propranolol—Erythema—Imiquimod—skin cancer	0.000704	0.00504	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000698	0.00499	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000697	0.00499	CcSEcCtD
Propranolol—Vomiting—Vismodegib—skin cancer	0.000693	0.00496	CcSEcCtD
Propranolol—Affect lability—Temozolomide—skin cancer	0.000689	0.00493	CcSEcCtD
Propranolol—Rash—Vismodegib—skin cancer	0.000687	0.00492	CcSEcCtD
Propranolol—Amnesia—Fluorouracil—skin cancer	0.000687	0.00492	CcSEcCtD
Propranolol—Dermatitis—Vismodegib—skin cancer	0.000687	0.00492	CcSEcCtD
Propranolol—Anaphylactic shock—Vemurafenib—skin cancer	0.000674	0.00482	CcSEcCtD
Propranolol—Infection—Vemurafenib—skin cancer	0.000669	0.00479	CcSEcCtD
Propranolol—Mood swings—Temozolomide—skin cancer	0.000663	0.00475	CcSEcCtD
Propranolol—Nervous system disorder—Vemurafenib—skin cancer	0.000661	0.00473	CcSEcCtD
Propranolol—Lethargy—Fluorouracil—skin cancer	0.000659	0.00471	CcSEcCtD
Propranolol—Skin disorder—Vemurafenib—skin cancer	0.000654	0.00468	CcSEcCtD
Propranolol—Nausea—Vismodegib—skin cancer	0.000648	0.00463	CcSEcCtD
Propranolol—Agitation—Imiquimod—skin cancer	0.000647	0.00463	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000631	0.00451	CcSEcCtD
Propranolol—Neutropenia—Dactinomycin—skin cancer	0.000626	0.00448	CcSEcCtD
Propranolol—Irritability—Fluorouracil—skin cancer	0.000616	0.00441	CcSEcCtD
Propranolol—Cough—Imiquimod—skin cancer	0.000614	0.0044	CcSEcCtD
Propranolol—Cardiac arrest—Fluorouracil—skin cancer	0.000614	0.00439	CcSEcCtD
Propranolol—Convulsion—Imiquimod—skin cancer	0.00061	0.00436	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000595	0.00426	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000592	0.00423	CcSEcCtD
Propranolol—Decreased appetite—Vemurafenib—skin cancer	0.000586	0.00419	CcSEcCtD
Propranolol—Bronchitis—Temozolomide—skin cancer	0.000582	0.00417	CcSEcCtD
Propranolol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000582	0.00416	CcSEcCtD
Propranolol—Fatigue—Vemurafenib—skin cancer	0.000581	0.00416	CcSEcCtD
Propranolol—Constipation—Vemurafenib—skin cancer	0.000576	0.00412	CcSEcCtD
Propranolol—Lightheadedness—Docetaxel—skin cancer	0.000574	0.00411	CcSEcCtD
Propranolol—Infection—Imiquimod—skin cancer	0.000571	0.00408	CcSEcCtD
Propranolol—Neutropenia—Temozolomide—skin cancer	0.000566	0.00405	CcSEcCtD
Propranolol—Nervous system disorder—Imiquimod—skin cancer	0.000563	0.00403	CcSEcCtD
Propranolol—Skin disorder—Imiquimod—skin cancer	0.000558	0.00399	CcSEcCtD
Propranolol—Erectile dysfunction—Temozolomide—skin cancer	0.000558	0.00399	CcSEcCtD
Propranolol—Agranulocytosis—Dactinomycin—skin cancer	0.000557	0.00399	CcSEcCtD
Propranolol—Infestation NOS—Temozolomide—skin cancer	0.00054	0.00386	CcSEcCtD
Propranolol—Infestation—Temozolomide—skin cancer	0.00054	0.00386	CcSEcCtD
Propranolol—Depression—Temozolomide—skin cancer	0.000538	0.00385	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000535	0.00383	CcSEcCtD
Propranolol—Body temperature increased—Vemurafenib—skin cancer	0.000532	0.00381	CcSEcCtD
Propranolol—Pharyngitis—Dactinomycin—skin cancer	0.000532	0.00381	CcSEcCtD
Propranolol—Insomnia—Imiquimod—skin cancer	0.00052	0.00372	CcSEcCtD
Propranolol—Paraesthesia—Imiquimod—skin cancer	0.000516	0.00369	CcSEcCtD
Propranolol—Cardiac failure congestive—Docetaxel—skin cancer	0.000514	0.00368	CcSEcCtD
Propranolol—Dyspnoea—Imiquimod—skin cancer	0.000512	0.00367	CcSEcCtD
Propranolol—Somnolence—Imiquimod—skin cancer	0.000511	0.00365	CcSEcCtD
Propranolol—Alopecia—Bleomycin—skin cancer	0.000508	0.00363	CcSEcCtD
Propranolol—Erythema multiforme—Dactinomycin—skin cancer	0.000507	0.00363	CcSEcCtD
Propranolol—Dyspepsia—Imiquimod—skin cancer	0.000506	0.00362	CcSEcCtD
Propranolol—Erythema—Bleomycin—skin cancer	0.0005	0.00358	CcSEcCtD
Propranolol—Decreased appetite—Imiquimod—skin cancer	0.000499	0.00357	CcSEcCtD
Propranolol—Infestation NOS—Fluorouracil—skin cancer	0.000497	0.00356	CcSEcCtD
Propranolol—Infestation—Fluorouracil—skin cancer	0.000497	0.00356	CcSEcCtD
Propranolol—Hypersensitivity—Vemurafenib—skin cancer	0.000496	0.00355	CcSEcCtD
Propranolol—Gastrointestinal disorder—Imiquimod—skin cancer	0.000496	0.00355	CcSEcCtD
Propranolol—Fatigue—Imiquimod—skin cancer	0.000495	0.00354	CcSEcCtD
Propranolol—Visual disturbance—Docetaxel—skin cancer	0.000492	0.00352	CcSEcCtD
Propranolol—Pain—Imiquimod—skin cancer	0.000491	0.00352	CcSEcCtD
Propranolol—Asthenia—Vemurafenib—skin cancer	0.000483	0.00346	CcSEcCtD
Propranolol—Hallucination—Temozolomide—skin cancer	0.000482	0.00345	CcSEcCtD
Propranolol—Pharyngitis—Temozolomide—skin cancer	0.000481	0.00344	CcSEcCtD
Propranolol—Lethargy—Docetaxel—skin cancer	0.000475	0.0034	CcSEcCtD
Propranolol—Alopecia—Dactinomycin—skin cancer	0.000473	0.00339	CcSEcCtD
Propranolol—Gastrointestinal pain—Imiquimod—skin cancer	0.00047	0.00336	CcSEcCtD
Propranolol—Visual impairment—Temozolomide—skin cancer	0.000467	0.00334	CcSEcCtD
Propranolol—Erythema—Dactinomycin—skin cancer	0.000466	0.00334	CcSEcCtD
Propranolol—Agranulocytosis—Fluorouracil—skin cancer	0.000464	0.00332	CcSEcCtD
Propranolol—Diarrhoea—Vemurafenib—skin cancer	0.000461	0.0033	CcSEcCtD
Propranolol—Erythema multiforme—Temozolomide—skin cancer	0.000458	0.00328	CcSEcCtD
Propranolol—Urticaria—Imiquimod—skin cancer	0.000456	0.00327	CcSEcCtD
Propranolol—Body temperature increased—Imiquimod—skin cancer	0.000454	0.00325	CcSEcCtD
Propranolol—Abdominal pain—Imiquimod—skin cancer	0.000454	0.00325	CcSEcCtD
Propranolol—Cardiac disorder—Temozolomide—skin cancer	0.00045	0.00322	CcSEcCtD
Propranolol—Dizziness—Vemurafenib—skin cancer	0.000445	0.00319	CcSEcCtD
Propranolol—Pharyngitis—Fluorouracil—skin cancer	0.000443	0.00317	CcSEcCtD
Propranolol—Cough—Bleomycin—skin cancer	0.000436	0.00312	CcSEcCtD
Propranolol—Vomiting—Vemurafenib—skin cancer	0.000428	0.00307	CcSEcCtD
Propranolol—Alopecia—Temozolomide—skin cancer	0.000428	0.00306	CcSEcCtD
Propranolol—Rash—Vemurafenib—skin cancer	0.000425	0.00304	CcSEcCtD
Propranolol—Mental disorder—Temozolomide—skin cancer	0.000424	0.00304	CcSEcCtD
Propranolol—Dermatitis—Vemurafenib—skin cancer	0.000424	0.00304	CcSEcCtD
Propranolol—Hypersensitivity—Imiquimod—skin cancer	0.000423	0.00303	CcSEcCtD
Propranolol—Erythema—Temozolomide—skin cancer	0.000422	0.00302	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000419	0.003	CcSEcCtD
Propranolol—Asthenia—Imiquimod—skin cancer	0.000412	0.00295	CcSEcCtD
Propranolol—Anaphylactic shock—Bleomycin—skin cancer	0.000408	0.00292	CcSEcCtD
Propranolol—Infection—Bleomycin—skin cancer	0.000405	0.0029	CcSEcCtD
Propranolol—Nausea—Vemurafenib—skin cancer	0.0004	0.00286	CcSEcCtD
Propranolol—Bronchospasm—Docetaxel—skin cancer	0.000396	0.00283	CcSEcCtD
Propranolol—Alopecia—Fluorouracil—skin cancer	0.000394	0.00282	CcSEcCtD
Propranolol—Diarrhoea—Imiquimod—skin cancer	0.000393	0.00281	CcSEcCtD
Propranolol—Erythema—Fluorouracil—skin cancer	0.000389	0.00278	CcSEcCtD
Propranolol—Agitation—Temozolomide—skin cancer	0.000388	0.00277	CcSEcCtD
Propranolol—Dizziness—Imiquimod—skin cancer	0.00038	0.00272	CcSEcCtD
Propranolol—Vertigo—Temozolomide—skin cancer	0.000379	0.00271	CcSEcCtD
Propranolol—Infection—Dactinomycin—skin cancer	0.000378	0.00271	CcSEcCtD
Propranolol—Neutropenia—Docetaxel—skin cancer	0.000376	0.00269	CcSEcCtD
Propranolol—Cough—Temozolomide—skin cancer	0.000368	0.00263	CcSEcCtD
Propranolol—Paraesthesia—Bleomycin—skin cancer	0.000366	0.00262	CcSEcCtD
Propranolol—Convulsion—Temozolomide—skin cancer	0.000365	0.00262	CcSEcCtD
Propranolol—Vomiting—Imiquimod—skin cancer	0.000365	0.00261	CcSEcCtD
Propranolol—Dyspnoea—Bleomycin—skin cancer	0.000364	0.0026	CcSEcCtD
Propranolol—Rash—Imiquimod—skin cancer	0.000362	0.00259	CcSEcCtD
Propranolol—Dermatitis—Imiquimod—skin cancer	0.000362	0.00259	CcSEcCtD
Propranolol—Infestation NOS—Docetaxel—skin cancer	0.000359	0.00257	CcSEcCtD
Propranolol—Infestation—Docetaxel—skin cancer	0.000359	0.00257	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000357	0.00255	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000356	0.00255	CcSEcCtD
Propranolol—Decreased appetite—Bleomycin—skin cancer	0.000355	0.00254	CcSEcCtD
Propranolol—Pain—Bleomycin—skin cancer	0.000349	0.0025	CcSEcCtD
Propranolol—Anaphylactic shock—Temozolomide—skin cancer	0.000344	0.00246	CcSEcCtD
Propranolol—Infection—Temozolomide—skin cancer	0.000342	0.00245	CcSEcCtD
Propranolol—Nausea—Imiquimod—skin cancer	0.000341	0.00244	CcSEcCtD
Propranolol—Nervous system disorder—Temozolomide—skin cancer	0.000338	0.00242	CcSEcCtD
Propranolol—Convulsion—Fluorouracil—skin cancer	0.000337	0.00241	CcSEcCtD
Propranolol—Agranulocytosis—Docetaxel—skin cancer	0.000335	0.0024	CcSEcCtD
Propranolol—Skin disorder—Temozolomide—skin cancer	0.000334	0.00239	CcSEcCtD
Propranolol—Decreased appetite—Dactinomycin—skin cancer	0.000331	0.00237	CcSEcCtD
Propranolol—Fatigue—Dactinomycin—skin cancer	0.000328	0.00235	CcSEcCtD
Propranolol—Pain—Dactinomycin—skin cancer	0.000325	0.00233	CcSEcCtD
Propranolol—Urticaria—Bleomycin—skin cancer	0.000324	0.00232	CcSEcCtD
Propranolol—Body temperature increased—Bleomycin—skin cancer	0.000323	0.00231	CcSEcCtD
Propranolol—Pharyngitis—Docetaxel—skin cancer	0.00032	0.00229	CcSEcCtD
Propranolol—Anaphylactic shock—Fluorouracil—skin cancer	0.000317	0.00227	CcSEcCtD
Propranolol—Infection—Fluorouracil—skin cancer	0.000315	0.00226	CcSEcCtD
Propranolol—Insomnia—Temozolomide—skin cancer	0.000311	0.00223	CcSEcCtD
Propranolol—Gastrointestinal pain—Dactinomycin—skin cancer	0.000311	0.00223	CcSEcCtD
Propranolol—Nervous system disorder—Fluorouracil—skin cancer	0.000311	0.00223	CcSEcCtD
Propranolol—Visual impairment—Docetaxel—skin cancer	0.000311	0.00222	CcSEcCtD
Propranolol—Paraesthesia—Temozolomide—skin cancer	0.000309	0.00221	CcSEcCtD
Propranolol—Dyspnoea—Temozolomide—skin cancer	0.000307	0.0022	CcSEcCtD
Propranolol—Somnolence—Temozolomide—skin cancer	0.000306	0.00219	CcSEcCtD
Propranolol—Erythema multiforme—Docetaxel—skin cancer	0.000305	0.00218	CcSEcCtD
Propranolol—Dyspepsia—Temozolomide—skin cancer	0.000303	0.00217	CcSEcCtD
Propranolol—Abdominal pain—Dactinomycin—skin cancer	0.000301	0.00215	CcSEcCtD
Propranolol—Body temperature increased—Dactinomycin—skin cancer	0.000301	0.00215	CcSEcCtD
Propranolol—Hypersensitivity—Bleomycin—skin cancer	0.000301	0.00215	CcSEcCtD
Propranolol—Decreased appetite—Temozolomide—skin cancer	0.000299	0.00214	CcSEcCtD
Propranolol—Cardiac disorder—Docetaxel—skin cancer	0.000299	0.00214	CcSEcCtD
Propranolol—Gastrointestinal disorder—Temozolomide—skin cancer	0.000297	0.00213	CcSEcCtD
Propranolol—Fatigue—Temozolomide—skin cancer	0.000297	0.00212	CcSEcCtD
Propranolol—Constipation—Temozolomide—skin cancer	0.000294	0.00211	CcSEcCtD
Propranolol—Pain—Temozolomide—skin cancer	0.000294	0.00211	CcSEcCtD
Propranolol—Asthenia—Bleomycin—skin cancer	0.000293	0.0021	CcSEcCtD
Propranolol—Insomnia—Fluorouracil—skin cancer	0.000287	0.00205	CcSEcCtD
Propranolol—Paraesthesia—Fluorouracil—skin cancer	0.000285	0.00204	CcSEcCtD
Propranolol—Alopecia—Docetaxel—skin cancer	0.000285	0.00204	CcSEcCtD
Propranolol—Dyspnoea—Fluorouracil—skin cancer	0.000283	0.00202	CcSEcCtD
Propranolol—Mental disorder—Docetaxel—skin cancer	0.000282	0.00202	CcSEcCtD
Propranolol—Somnolence—Fluorouracil—skin cancer	0.000282	0.00202	CcSEcCtD
Propranolol—Gastrointestinal pain—Temozolomide—skin cancer	0.000281	0.00201	CcSEcCtD
Propranolol—Erythema—Docetaxel—skin cancer	0.00028	0.00201	CcSEcCtD
Propranolol—Hypersensitivity—Dactinomycin—skin cancer	0.00028	0.00201	CcSEcCtD
Propranolol—Dyspepsia—Fluorouracil—skin cancer	0.000279	0.002	CcSEcCtD
Propranolol—Decreased appetite—Fluorouracil—skin cancer	0.000276	0.00197	CcSEcCtD
Propranolol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000274	0.00196	CcSEcCtD
Propranolol—Urticaria—Temozolomide—skin cancer	0.000273	0.00196	CcSEcCtD
Propranolol—Asthenia—Dactinomycin—skin cancer	0.000273	0.00195	CcSEcCtD
Propranolol—Body temperature increased—Temozolomide—skin cancer	0.000272	0.00195	CcSEcCtD
Propranolol—Abdominal pain—Temozolomide—skin cancer	0.000272	0.00195	CcSEcCtD
Propranolol—Pain—Fluorouracil—skin cancer	0.000271	0.00194	CcSEcCtD
Propranolol—Diarrhoea—Dactinomycin—skin cancer	0.00026	0.00186	CcSEcCtD
Propranolol—Vomiting—Bleomycin—skin cancer	0.000259	0.00186	CcSEcCtD
Propranolol—Rash—Bleomycin—skin cancer	0.000257	0.00184	CcSEcCtD
Propranolol—Dermatitis—Bleomycin—skin cancer	0.000257	0.00184	CcSEcCtD
Propranolol—Hypersensitivity—Temozolomide—skin cancer	0.000254	0.00182	CcSEcCtD
Propranolol—Urticaria—Fluorouracil—skin cancer	0.000252	0.0018	CcSEcCtD
Propranolol—Body temperature increased—Fluorouracil—skin cancer	0.000251	0.00179	CcSEcCtD
Propranolol—Asthenia—Temozolomide—skin cancer	0.000247	0.00177	CcSEcCtD
Propranolol—Cough—Docetaxel—skin cancer	0.000245	0.00175	CcSEcCtD
Propranolol—Convulsion—Docetaxel—skin cancer	0.000243	0.00174	CcSEcCtD
Propranolol—Nausea—Bleomycin—skin cancer	0.000242	0.00173	CcSEcCtD
Propranolol—Vomiting—Dactinomycin—skin cancer	0.000242	0.00173	CcSEcCtD
Propranolol—Rash—Dactinomycin—skin cancer	0.00024	0.00172	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000237	0.0017	CcSEcCtD
Propranolol—Diarrhoea—Temozolomide—skin cancer	0.000236	0.00169	CcSEcCtD
Propranolol—Hypersensitivity—Fluorouracil—skin cancer	0.000234	0.00167	CcSEcCtD
Propranolol—Anaphylactic shock—Docetaxel—skin cancer	0.000229	0.00164	CcSEcCtD
Propranolol—Dizziness—Temozolomide—skin cancer	0.000228	0.00163	CcSEcCtD
Propranolol—Infection—Docetaxel—skin cancer	0.000227	0.00163	CcSEcCtD
Propranolol—Nausea—Dactinomycin—skin cancer	0.000226	0.00162	CcSEcCtD
Propranolol—Nervous system disorder—Docetaxel—skin cancer	0.000224	0.00161	CcSEcCtD
Propranolol—Skin disorder—Docetaxel—skin cancer	0.000222	0.00159	CcSEcCtD
Propranolol—Vomiting—Temozolomide—skin cancer	0.000219	0.00157	CcSEcCtD
Propranolol—Rash—Temozolomide—skin cancer	0.000217	0.00155	CcSEcCtD
Propranolol—Diarrhoea—Fluorouracil—skin cancer	0.000217	0.00155	CcSEcCtD
Propranolol—Dermatitis—Temozolomide—skin cancer	0.000217	0.00155	CcSEcCtD
Propranolol—Dizziness—Fluorouracil—skin cancer	0.00021	0.0015	CcSEcCtD
Propranolol—Insomnia—Docetaxel—skin cancer	0.000207	0.00148	CcSEcCtD
Propranolol—Paraesthesia—Docetaxel—skin cancer	0.000206	0.00147	CcSEcCtD
Propranolol—Nausea—Temozolomide—skin cancer	0.000204	0.00146	CcSEcCtD
Propranolol—Dyspnoea—Docetaxel—skin cancer	0.000204	0.00146	CcSEcCtD
Propranolol—Somnolence—Docetaxel—skin cancer	0.000204	0.00146	CcSEcCtD
Propranolol—Vomiting—Fluorouracil—skin cancer	0.000202	0.00144	CcSEcCtD
Propranolol—Dyspepsia—Docetaxel—skin cancer	0.000202	0.00144	CcSEcCtD
Propranolol—Rash—Fluorouracil—skin cancer	0.0002	0.00143	CcSEcCtD
Propranolol—Dermatitis—Fluorouracil—skin cancer	0.0002	0.00143	CcSEcCtD
Propranolol—Decreased appetite—Docetaxel—skin cancer	0.000199	0.00142	CcSEcCtD
Propranolol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000198	0.00141	CcSEcCtD
Propranolol—Fatigue—Docetaxel—skin cancer	0.000197	0.00141	CcSEcCtD
Propranolol—Pain—Docetaxel—skin cancer	0.000196	0.0014	CcSEcCtD
Propranolol—Constipation—Docetaxel—skin cancer	0.000196	0.0014	CcSEcCtD
Propranolol—Nausea—Fluorouracil—skin cancer	0.000188	0.00135	CcSEcCtD
Propranolol—Gastrointestinal pain—Docetaxel—skin cancer	0.000187	0.00134	CcSEcCtD
Propranolol—Abdominal pain—Docetaxel—skin cancer	0.000181	0.0013	CcSEcCtD
Propranolol—Body temperature increased—Docetaxel—skin cancer	0.000181	0.0013	CcSEcCtD
Propranolol—Hypersensitivity—Docetaxel—skin cancer	0.000169	0.00121	CcSEcCtD
Propranolol—Asthenia—Docetaxel—skin cancer	0.000164	0.00118	CcSEcCtD
Propranolol—Diarrhoea—Docetaxel—skin cancer	0.000157	0.00112	CcSEcCtD
Propranolol—Dizziness—Docetaxel—skin cancer	0.000151	0.00108	CcSEcCtD
Propranolol—Vomiting—Docetaxel—skin cancer	0.000146	0.00104	CcSEcCtD
Propranolol—Rash—Docetaxel—skin cancer	0.000144	0.00103	CcSEcCtD
Propranolol—Dermatitis—Docetaxel—skin cancer	0.000144	0.00103	CcSEcCtD
Propranolol—Nausea—Docetaxel—skin cancer	0.000136	0.000973	CcSEcCtD
